MAP2K1 and acute myeloid leukemia: Thirty-seven proteins positively correlated with Gal-3 protein expression levels in patients with AML, including the unmodified protein MAP2K1 (MEK1) and the phospho-proteins Protein Kinase B (AKT; pT308), Extracellular Receptor Kinase (ERK; pY202/pY204), Protein Kinase C (PKC) δ (pT507, pS645, and pS664) and PKC α (pS657), and SRC (pY416 and pY527) [64].